Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Ask Michael Burke -- Ignore unavailable to you. Want to Upgrade?

To: wlheatmoon who wrote (39443)	12/15/1998 11:20:00 AM
From: Knighty Tin	Read Replies (1) \| Respond to of 132070

MKC, I like Incyte and hold some spreads in my income accounts. However, I think it has gotten way ahead of itself. I already sold the straight longs I bought at 22 and change. Incyte is my favorite genomics co. I also like HGSI and GENE. But Perkin-Elmer's new products cast a shadow over all of them. True, right now PKN is only hitting the lower end, which is a small part of INCY's business. But that is the bugaboo that took the stock down in the first place. And I expect it to keep a ceiling on appreciation. I wouldn't buy a new position here. Try to get it under $30. MB